Placebo News and Research

RSS

FDA approves Risperdal to treat irritability associated with autism

The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.

8 Oct 2006

Feeling stressed? have a cuppa...then have another!

According to the latest research regular cups of tea can help speed recovery from stress.

5 Oct 2006

New drug a breakthrough in the treatment of AMD

Age-related macular degeneration (AMD), is a common cause of vision loss and often affects older people.

5 Oct 2006

Six shot course gives two year protection from hay fever

An experimental vaccine is promising to prevent hay fever symptoms for at least two years, and this is after just six injections.

5 Oct 2006

Taking sildenafil will worsen sleep apnea

According to Brazilian researchers, taking Viagra (sildenafil) at bedtime may aggravate breathing problems in patients with severe obstructive sleep apnea.

4 Oct 2006

Progesterone improves outcomes for victims of traumatic brain injury

A new study suggests that giving progesterone to victims with Traumatic Brain Injury (TBI) shortly following brain injury may reduce the risk of death and the degree of disability, and appears to be safe.

3 Oct 2006

Raloxifene reduces breast cancer risk in postmenopausal women

Raloxifene protects postmenopausal women from developing invasive breast cancer whether they are at high or low risk of developing the disease, according to a new study.

13 Sep 2006

Nicotine shows potential medical benefits

Nicotine may improve the symptoms of depression in people who do not smoke, Duke University Medical Center scientists have discovered.

12 Sep 2006

SSRIs associated with severe violence in a small number of individuals

Use of one class of antidepressant drugs, the SSRIs (selective serotonin reuptake inhibitors), may be associated with severe violence in a small number of individuals say the authors of paper published in PLoS Medicine.

12 Sep 2006

Rivastigmine improves memory loss for traumatic brain injury patients

Traumatic brain injury patients with moderate to severe memory loss improved their memories while taking the drug rivastigmine, according to a study published in the September 12, 2006, issue of Neurology.

12 Sep 2006

Drug infliximab may help ease ulcerative colitis

In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder, a new research review suggests that the drug infliximab can be a useful alternative if other treatments don't work.

12 Sep 2006

Zolmitriptan nasal spray may be safe and effective in treating painful cluster headaches

Zolmitriptan nasal spray, used to treat migraine headaches, also may be safe and effective in treating painful cluster headaches, according to an article posted online today that will appear in the November 2006 print issue of Archives of Neurology.

12 Sep 2006

FDA approves Watson's generic version of Barr's contraceptive pill Seasonale

FDA on Thursday approved Watson Pharmaceuticals' marketing application for its generic version of Barr Laboratories' extended-cycle oral contraceptive Seasonale, Reuters reports.

11 Sep 2006

New drug sorts out premature ejaculation

According the American Urological Association, premature ejaculation affects about 20% of males in the U.S. aged 18-59.

11 Sep 2006

Trial shows H5N1 vaccine safe and effective

A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.

7 Sep 2006

SSRI's developed for premature ejaculation, safe and effective

A selective serotonin reuptake inhibitor (SSRI) developed specifically for the treatment of premature ejaculation is safe and effective for men severely affected by the condition, according to an Article in this week's issue of The Lancet.

7 Sep 2006

Tenecteplase study halted

World Congress of Cardiology 2006 - Thrombolytic Therapy, given during cardiopulmonary resuscitation (CPR) in out-ofhospital cardiac arrests, may be no better than placebo.

6 Sep 2006

Immunotherapy for heart failure

World Congress of Cardiology Report - Heart failure (HF) is a complex, progressive clinical syndrome that can result from any structural or functional cardiac disorder, such as coronary artery disease or hypertension (high blood pressure), which impairs the ability of the heart to function properly as a pump.

5 Sep 2006

VIOXX reduces risk of colorectal polyps

A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.

30 Aug 2006

Celebrex shown to reduce incidence of potentially pre-malignant colorectal polyps

An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.

30 Aug 2006